Neuromonitoring Company Founded by Former NFL Quarterback Set to Go Public

Source:   ()
Assure Holdings, an intraoperative neuromonitoring company founded by former NFL quarterback Preston Parsons, will begin trading on the TSX Venture Exchange on May 29, under the trading symbol IOM. read more >

What Is Chen Buying? Gold, Cobalt, Phosphate and Biotech. . .

Contributed Opinion
Source:   ()
With the market in flux, Chen Lin of the popular newsletter What Is Chen Buying?, What Is Chen Selling? is hedging his bets with investments in a variety of companies in different sectors. read more >

The Zinc Race Is Heating Up and One Company Just Made a Big Move Forward

Source:   ()
Trevali Mining added new weapons to its zinc arsenal by acquiring interest in Glencore's African zinc mines. read more >

An Action-Packed Exploration Year for These Three Companies

Contributed Opinion
Source:   ()
As the first half of 2017 comes to a close, Thibaut Lepouttre, editor of Caesars Report, takes a close look at three companies with hot prospects for a productive second half. read more >

Rare Earths and Gold Projects Advancing in Australia

Source:   ()
A recent report by Edison Investment Research has Alkane Resources back on track at its Tomingley Gold Operations after disruptive rains, and development is continuing at the multi-commodity Dubbo Project. read more >

Small-Caps Rushing to Fill the NASH Treatment Pipeline

Source:   ()
NASH is an epidemic in the U.S., with more than 100 million people believed to be affected. Yet no FDA-approved treatments are available, with the exception of liver transplantation for end-stage disease. In part two of his interview with The Life Sciences Report, Ed Arce, managing director in equity research and senior analyst covering companies in the biopharmaceuticals and specialty pharmaceuticals sectors for H.C. Wainwright, and organizer of the recent inaugural NASH Investor Conference, says that small companies are rushing to fill the pipeline, with numerous compounds in trials. read more >

Innovative Company Focused on Women's Health Completes Record-Breaking Quarter

Source:   ()
Viveve Medical's Q1/17 results beat expectations, an accomplishment that was welcomed by several industry analysts. read more >
Expert Investing Ideas

"SNSS' SNS-062 Phase Ib/II is expected to begin in H1/17."

–Maxim Jacobs, Edison Investment Research


"PVG is on the verge of pouring its first bar of gold."

The Gold Report Interview with Louis James


Castle Silver Should be Called Castle Cobalt

Contributed Opinion
Source:   ()
With the price of cobalt increasing, Bob Moriarty of 321 Gold profiles Castle Silver, which has turned its focus to cobalt. read more >

Disputes, Higher Dividends and New Study: Mostly Good News 

Contributed Opinion
Source:   ()
Money manager Adrian Day reviews news from several companies, mostly positive developments, and notes that some stocks are good buys at current levels.  read more >

In Times of Rate Hikes, Industrial Metals Rise Fastest

Contributed Opinion
Source:   ()
Tom Beck, senior editor of Portfolio Wealth Global, says in times of rate hikes, industrial metals rise fastest, and in today's world, the type of metals in highest demand by China are going to rise the most. read more >

The Market Will Tank Hard

Contributed Opinion
Source:   ()
The script for 2017-2018: Melt Up, then Global Meltdown, says Lior Gantz, editor of Wealth Research Group, who sees industrial metals, specifically silver and zinc, leading a commodities charge, while broad indices take a nose dive. read more >